Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 6,897,652 | 6,897,652 | 0 | $303.84M | $339.09M | 32.95% | +$35.25M |
| Mineralys Therapeutics, Inc.(MLYS) | 5,871,018 | 5,871,018 | 0 | $213.06M | $159.05M | 15.45% | -$54.01M |
| Alumis Inc | 5,756,984 | 6,345,219 | +588,235 | $56.19M | $139.79M | 13.58% | +$83.60M |
| Septerna, Inc.(SEPN) | 3,149,128 | 3,149,128 | 0 | $87.80M | $75.67M | 7.35% | -$12.12M |
| Kalaris Therapeutics, Inc.(KLRS) | 12,948,081 | 12,948,081 | 0 | $109.28M | $74.71M | 7.26% | -$34.57M |
| SpyGlass Pharma, Inc.(SGP) | 0 | 2,109,953 | +2,109,953 | $0 | $54.67M | 5.31% | +$54.67M |
| Neurogene Inc.(NGNE) | 1,717,127 | 1,717,127 | 0 | $35.37M | $34.62M | 3.36% | -$755.5K |
| Inventiva S.A.ADS(IVA) | 5,194,805 | 5,194,805 | 0 | $24.16M | $28.83M | 2.80% | +$4.68M |
| Sutro Biopharma, Inc.(STRO) | 204,503 | 1,062,872 | +858,369 | $2.37M | $26.48M | 2.57% | +$24.11M |
| Jade Biosciences Inc | 968,798 | 968,798 | 0 | $14.95M | $13.61M | 1.32% | -$1.34M |
| vTv Therapeutics Inc.CL A(VTVT) | 298,496 | 298,496 | 0 | $11.94M | $11.84M | 1.15% | -$98.5K |
| Aquestive Therapeutics Inc | 2,500,000 | 2,500,000 | 0 | $16.15M | $10.38M | 1.01% | -$5.78M |
| X4 Pharmaceuticals, Inc.(XFOR) | 1,960,000 | 1,832,566 | -127,434 | $7.84M | $7.57M | 0.74% | -$271.5K |
| Nkarta, Inc.(NKTX) | 3,507,666 | 3,507,666 | 0 | $6.49M | $7.40M | 0.72% | +$912.0K |
| Arcellx Inc COMMON STOCK | 60,873 | 60,873 | 0 | $3.97M | $6.99M | 0.68% | +$3.02M |
| Upstream Bio, Inc.(UPB) | 736,047 | 736,047 | 0 | $19.98M | $6.62M | 0.64% | -$13.36M |
| ABIVAX Société AnonymeADS(ABVX) | 75,442 | 56,581 | -18,861 | $10.17M | $6.30M | 0.61% | -$3.87M |
| AgomAb Therapeutics NVADS(AGMB) | 0 | 600,000 | +600,000 | $0 | $6.29M | 0.61% | +$6.29M |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 8,500,000 | 8,500,000 | 0 | $11.47M | $6.25M | 0.61% | -$5.23M |
| Coherus Oncology, Inc.(CHRS) | 0 | 3,428,571 | +3,428,571 | $0 | $5.79M | 0.56% | +$5.79M |
| Palvella Therapeutics, Inc.(PVLA) | 104,817 | 38,432 | -66,385 | $10.97M | $4.79M | 0.47% | -$6.18M |
| Gossamer Bio, Inc.(GOSS) | 7,222,559 | 7,222,559 | 0 | $22.39M | $2.37M | 0.23% | -$20.02M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 72,245 | 0 | -72,245 | $825.8K | $0 | — | -$825.8K |
| Nuvation Bio Inc.W EXP 02 10 202(NUVB) | 124,119 | 0 | -124,119 | $41.0K | $0 | — | -$41.0K |